Toctino gets final NICE approval
This article was originally published in Scrip
Executive Summary
Basilea Pharmaceutica's Toctino (alitretinoin) should be a treatment option for adults in England and Wales with severe chronic hand eczema that has not responded to potent topical corticosteroids, NICE has recommended.